Clinical trial
A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Goofice® in Patients With Chronic Constipation
NCT05895877 is registered in ClinicalTrials.gov with Synmosa Biopharma Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Goofice® in Patients With Chronic Constipation
- Lead sponsor
- Synmosa Biopharma Corp.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 21, 2021
- Completion date
- September 30, 2023
- Enrollment
- 351 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.